Biologist Prof. Dr. Tobias Ackels (40) from the University of Bonn will be awarded the Paul Ehrlich and Ludwig Darmstaedter Early Career Award 2025,  the Scientific Council of the Paul Ehrlich ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of β-glucans. These are natural sugar compounds found in bacteria, fungi and ...

Paul Ehrlich (1854-1915) was born in East Prussia (now Poland), the son of a lottery-office keeper. He went to the University of Leipzig to pursue a career in medicine. By the time he graduated in ...

This year marks the 100th anniversary of the award of the Nobel Prize for Physiology or Medicine to Paul Ehrlich, in recognition of his contribution to immunology. His impact, however, extended ...

CAR T-cell therapies have established themselves as a frequently very successful and overall promising treatment option for various blood cancers for which no other effective therapies are available.

Compiled and edited by Dr. F. Himmelweit, with the assistance of the late Martha Marquardt. Under the editorial direction of Sir Henry Dale. Vol. 2: Immunology and Cancer Research. Pp. viii + 562 ...

RELEASE THE RECEPTORS: According to Ehrlich’s side-chain theory —depicted here in a diagram used to illustrate his lecture to the Royal Society of London in 1900—immune cells were dotted with a vast ...

Oncolytics Biotech Inc shares T.ONC are trading unchanged at $1.17. Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to ...

Biologist Prof. Dr. Tobias Ackels (40) from the University of Bonn will be awarded the Paul Ehrlich and Ludwig Darmstaedter Early Career Award 2025, the Scientific Council of the Paul Ehrlich ...